|Bid||3.0000 x 4000|
|Ask||3.0200 x 3000|
|Day's Range||2.9300 - 3.0400|
|52 Week Range||2.7300 - 7.5000|
|Beta (5Y Monthly)||-0.65|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 04, 2020 - Nov 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||13.25|
Investors need to pay close attention to Evofem Biosciences (EVFM) stock based on the movements in the options market lately.
Image source: The Motley Fool. Evofem Biosciences, Inc. (NASDAQ: EVFM)Q2 2020 Earnings CallAug 4, 2020, 11:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorLadies and gentlemen, thank you for standing by and welcome to the Evofem Biosciences Second Quarter 2020 Financial Results Conference Call.
Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), a commercial stage biopharmaceutical company, today reported financial results for the three- and six- month periods ended June 30, 2020.